Emerald Acquisition’s Harte-Hanks HHS Stock Holding History

Emerald Acquisition’s Portfolio HHS Stock Details HHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-8,022	Closed	-$127K	–	3007
2016 Q2	$127K	Buy	+8,022	New	+$142K	﹤0.01%	2802

Other funds holding HHS

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EVC

Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Emerald Acquisition's HHS Position: Q3 2016 in Review

Emerald Acquisition sold out of Harte-Hanks (HHS) in Q3 2016, closing a stake of 8,022 shares — an estimated $127K sold.

Emerald Acquisition first reported a position in HHS in Q2 2016 and held it in 1 quarter. The position peaked at $127K in Q2 2016. 102 funds tracked by Wall St. Rank hold HHS as of Q3 2016.

Emerald Acquisition reported no remaining Harte-Hanks position as of Q3 2016 after selling out during the quarter.
Emerald Acquisition sold 8,022 Harte-Hanks shares in Q3 2016, an estimated $127K.
Emerald Acquisition first reported a position in Harte-Hanks in Q2 2016 and held it in 1 quarter.
Emerald Acquisition's Harte-Hanks position peaked at $127K in Q2 2016.
102 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.